Hinge Health, Inc. (HNGE)
| Market Cap | 3.47B |
| Revenue (ttm) | 587.86M |
| Net Income (ttm) | -424.09M |
| Shares Out | 77.37M |
| EPS (ttm) | -7.77 |
| PE Ratio | n/a |
| Forward PE | 22.57 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 853,365 |
| Open | 44.97 |
| Previous Close | 45.03 |
| Day's Range | 44.40 - 45.99 |
| 52-Week Range | 30.08 - 62.18 |
| Beta | n/a |
| Analysts | Strong Buy |
| Price Target | 58.25 (+29.82%) |
| Earnings Date | May 5, 2026 |
About HNGE
Hinge Health, Inc. focuses on building a health system that scales and automates the delivery of care using technology. It designs its platform to address musculoskeletal system care (MSK), including acute injury, chronic pain, and post-surgical rehabilitation. The company also provides personalized and automated MSK care through AI-powered motion tracking technology and a proprietary electrical nerve stimulation wearable device. It primarily serves self-insured employers. The company was founded in 2012 and is headquartered in San Francisco, C... [Read more]
Financial Performance
In 2025, Hinge Health's revenue was $587.86 million, an increase of 50.58% compared to the previous year's $390.40 million. Losses were -$424.09 million, 3453.9% more than in 2024.
Financial StatementsAnalyst Forecast
According to 17 analysts, the average rating for HNGE stock is "Strong Buy." The 12-month stock price target is $58.25, which is an increase of 29.82% from the latest price.
News
Hinge Health to announce first quarter 2026 financial results on May 5, 2026
SAN FRANCISCO--(BUSINESS WIRE)--Hinge Health, Inc. (NYSE: HNGE) announced today that it will report its financial results for the quarter ended March 31, 2026, after the U.S. financial markets close o...
Hinge Health now supports over 300 public sector organizations including 24 state governments
SAN FRANCISCO--(BUSINESS WIRE)--Hinge Health, Inc. (NYSE: HNGE) today announced its expansion throughout the public sector, now delivering musculoskeletal (MSK) care to employees across 24 state emplo...
Hinge Health appoints Tyler Sloat to its board of directors
SAN FRANCISCO--(BUSINESS WIRE)--Hinge Health, Inc. (NYSE: HNGE) today announced the addition of Tyler Sloat to its board of directors. Sloat currently serves as the Chief Financial Officer and Chief O...
Why Is Hinge Health Stock Soaring Wednesday?
Hinge Health Inc. (NYSE: HNGE) stock rose Wednesday after the company reported better-than-expected fourth-quarter earnings.
Hinge Health Earnings Call Transcript: Q4 2025
Delivered record 2025 results with 51% revenue growth, 31% free cash flow margin, and strong client expansion. Guidance for 2026 projects 25% revenue growth and continued profitability, with investments in AI and Hinge Select positioning for long-term market leadership.
Hinge Health reports fourth quarter and full year 2025 financial results
SAN FRANCISCO--(BUSINESS WIRE)--Hinge Health, Inc. (NYSE: HNGE) today announced record financial results for the quarter and year ended December 31, 2025. “We closed out the year with an exceptional q...
Hinge Health's 2026 State of Musculoskeletal Care Report reveals stark gaps in traditional care
SAN FRANCISCO--(BUSINESS WIRE)--Today, Hinge Health (NYSE: HNGE) released its sixth annual State of Musculoskeletal (MSK) Care Report, revealing how today's fragmented healthcare system leaves many pe...
Hinge Health to announce fourth quarter and full year 2025 financial results on February 10, 2026
SAN FRANCISCO--(BUSINESS WIRE)--Hinge Health Q4 2025 earnings date press release.
Hinge Health Reduces MRIs and X-Rays for Back Pain by 60%
SAN FRANCISCO--(BUSINESS WIRE)--Hinge Health, Inc. (NYSE: HNGE) today announced a new study showing that participants in its chronic back pain program had substantially fewer imaging visits, such as X...
Hinge Health announces $250 million share repurchase program
SAN FRANCISCO--(BUSINESS WIRE)--Hinge Health, Inc. (NYSE: HNGE) today announced that its board of directors has authorized a $250 million share repurchase program. “During the first three quarters of ...
Hinge Health CEO Daniel Perez talks quarterly results as stock sinks 5%
Hinge Health CEO Daniel Perez talks quarterly results as stock sinks 5%.
Hinge Health Earnings Call Transcript: Q3 2025
Q3 revenue grew 53% year-over-year to $154M, with gross margin at 83% and operating margin at 20%. Strong client growth, robust free cash flow, and AI-driven efficiency led to raised full-year guidance and continued investment in R&D and new products.
Hinge Health reports third quarter 2025 financial results
SAN FRANCISCO--(BUSINESS WIRE)--Hinge Health, Inc. (NYSE: HNGE) today announced financial results for the third quarter ended September 30, 2025. “With healthcare costs rising dramatically, our missio...
Hinge Health unveils new AI-powered care tools
SAN FRANCISCO--(BUSINESS WIRE)--Hinge Health, Inc. (NYSE:HNGE) today announced two AI-powered care tools: Movement Analysis uses computer vision to set a new standard for tracking musculoskeletal (MSK...
Hinge Health to announce third quarter 2025 financial results on November 4, 2025
SAN FRANCISCO--(BUSINESS WIRE)--Hinge Health, Inc. (NYSE: HNGE) announced today that it will report its financial results for the quarter ended September 30, 2025, after the U.S. markets close on Tues...
Our vision is to use technology to scale healthcare, says Hinge Health CEO Daniel Perez
Hinge Health Co-Founder and CEO Daniel Perez joins 'Mad Money' host Jim Cramer to talk quarterly results, launching an in-person provider network, and more.
Hinge Health CEO on Q2 earnings since IPO, AI usage and growth
Daniel Perez, Hinge Health CEO, joins 'Closing Bell: Overtime' to discuss the company's Q2 earnings, AI initiatives and growth.
Hinge Health stock pops 10% after first quarterly report since IPO
Shares of Hinge Health popped after the digital physical therapy company reported quarterly results that beat analysts' estimates for revenue. The company reported quarterly results for the first time...
Hinge Health Earnings Call Transcript: Q2 2025
Q2 2025 saw 55% year-over-year revenue growth to $139M, with strong operating and free cash flow margins. Guidance for 2025 was raised, driven by higher eligible lives, improved yields, and product innovation, including the launch of Hinge Select.
Hinge Health Reports Second Quarter 2025 Financial Results
SAN FRANCISCO--(BUSINESS WIRE)--Hinge Health, Inc. (NYSE: HNGE) today announced financial results for the second quarter ended June 30, 2025. "In Q2 we delivered year-over-year revenue growth of 55% a...
Hinge Health to announce second quarter 2025 financial results on August 5, 2025
SAN FRANCISCO--(BUSINESS WIRE)--Hinge Health, Inc. (NYSE: HNGE) announced today that it will report its financial results for the quarterly period ended June 30, 2025, after the close of the market on...
Hinge Health Announces HingeSelect - a High-performance Network Delivering Unified Musculoskeletal Care
SAN FRANCISCO--(BUSINESS WIRE)--Hinge Health, Inc. (NYSE:HNGE), today announced the launch of HingeSelect, a high-performance provider network for musculoskeletal (MSK) care. Hinge Health's technology...
Hinge Health's Tech Is Primed To Capture America's Untapped MSK Pain Market: Analyst
In May, Hinge Health Inc HNGE priced its initial public offering of 13.7 million shares at $32 per share.
Fully insured medical claims analysis shows significant cost savings and 2.4x ROI for Hinge Health populations
SAN FRANCISCO--(BUSINESS WIRE)--Hinge Health, Inc. (NYSE: HNGE) today announced results from a medical claims analysis revealing an average $2,343 savings per member per year on care for chronic muscu...
Here's how newly public Hinge Health wants to use AI to automate more care delivery and bring in more cash
Physical therapy company Hinge Health finally went public Thursday. Its CEO says Hinge Health is banking on AI to automate care as it expands beyond physical therapy.